Literature DB >> 2108023

Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes.

D Noort1, M W Coughtrie, B Burchell, G A van der Marel, J H van Boom, A van der Gen, G J Mulder.   

Abstract

A series of possible transition state analogues of the glucuronidation reaction catalyzed by UDP-glucuronosyltransferase were tested for their inhibitory effect on glucuronidation of various substrates in a rat liver microsomal fraction. In general 4-nitrophenol glucuronidation was more effectively inhibited than that of 1-naphthol, bilirubin or testosterone. 2-(1-Naphthyl)ethyl-UDP and 2,2,2-(triphenyl)ethyl-UDP were the most effective inhibitors. Their inhibitory effect was competitive towards both UDP-glucuronic acid and 4-nitrophenol. These compounds were much more effective inhibitors than UDP; therefore addition of a lipophilic group enhances the inhibitory potency of UDP. The various UDP derivatives showed differences in their abilities to inhibit the glucuronidation of the four acceptor substrates, supporting the concept that the different forms of UDP-glucuronosyl transferase have different active sites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108023     DOI: 10.1111/j.1432-1033.1990.tb15404.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor.

Authors:  R L Bell; J Bouska; P R Young; C Lanni; J Machinist; P E Malo; J B Summers; D W Brooks; G W Carter
Journal:  Agents Actions       Date:  1993-03

2.  Cytosylglucuronic acid synthase (cytosine: UDP-glucuronosyltransferase) from Streptomyces griseochromogenes, the first prokaryotic UDP-glucuronosyltransferase.

Authors:  S J Gould; J Guo
Journal:  J Bacteriol       Date:  1994-03       Impact factor: 3.490

Review 3.  UDP-glucuronosyltransferase inhibitors.

Authors:  E Golovinsky; Z Naydenova; K Grancharov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.